137 related articles for article (PubMed ID: 10761013)
21. T-cell prolymphocytic leukemia: update and focus on alemtuzumab (Campath-1H).
Cao TM; Coutre SE
Hematology; 2003 Feb; 8(1):1-6. PubMed ID: 12623420
[TBL] [Abstract][Full Text] [Related]
22. [Clinical and laboratory features of T-cell prolymphocytic leukemia in China].
Zhang YR; Qi JY; Liu HM; Liu W; Huang WY; Deng SH; Yi SH; Xu Y; Li ZJ; Fu MW; Zou DH; Zhao YZ; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2013 Oct; 34(10):839-43. PubMed ID: 24171956
[TBL] [Abstract][Full Text] [Related]
23. T-cell prolymphocytic leukemia: a single-institution experience.
Ravandi F; O'Brien S; Jones D; Lerner S; Faderl S; Ferrajoli A; Wierda W; Garcia-Manero G; Thomas D; Koller C; Verstovsek S; Giles F; Cortes J; Herling M; Kantarjian H; Keating M
Clin Lymphoma Myeloma; 2005 Nov; 6(3):234-9. PubMed ID: 16354329
[TBL] [Abstract][Full Text] [Related]
24. Current treatment options in prolymphocytic leukemia.
Robak T; Robak P
Med Sci Monit; 2007 Apr; 13(4):RA69-80. PubMed ID: 17392661
[TBL] [Abstract][Full Text] [Related]
25. Indolent course as a relatively frequent presentation in T-prolymphocytic leukaemia. Groupe Français d'Hématologie Cellulaire.
Garand R; Goasguen J; Brizard A; Buisine J; Charpentier A; Claisse JF; Duchayne E; Lagrange M; Segonds C; Troussard X; Flandrin G
Br J Haematol; 1998 Nov; 103(2):488-94. PubMed ID: 9827924
[TBL] [Abstract][Full Text] [Related]
26. [T-cell prolymphocytic leukemia complicated by diffuse large B-cell lymphoma of the stomach].
Miyata A; Yoshino T; Kojima K; Fujii S; Kikuchi T
Rinsho Ketsueki; 2001 Jan; 42(1):47-50. PubMed ID: 11235134
[TBL] [Abstract][Full Text] [Related]
27. Recurrence of T-Cell Prolymphocytic Leukemia With a Rare Presentation as Diffuse Generalized Skin Lesion.
Wasifuddin M; Sabzposh H; Sun L; Wu R; Wang JC
J Investig Med High Impact Case Rep; 2023; 11():23247096231176223. PubMed ID: 37219076
[TBL] [Abstract][Full Text] [Related]
28. Prolymphocytic leukaemia.
Catovsky D
Nouv Rev Fr Hematol (1978); 1982; 24(6):343-7. PubMed ID: 6762526
[TBL] [Abstract][Full Text] [Related]
29. Cytogenetic studies on prolymphocytic leukemia. 1. B-cell prolymphocytic leukemia.
Brito-Babapulle V; Pittman S; Melo JV; Pomfret M; Catovsky D
Hematol Pathol; 1987; 1(1):27-33. PubMed ID: 3509770
[TBL] [Abstract][Full Text] [Related]
30. T-cell prolymphocytic leukemia (T-PLL) with overlapping cytomorphological features with T-CLL and T-ALL: a case initially diagnosed by fine-needle aspiration cytology and immunocytochemistry.
Das DK; Pathan SK; Joneja M; Al-Musawi FA; John B; Mirza KR
Diagn Cytopathol; 2013 Apr; 41(4):360-5. PubMed ID: 21987484
[TBL] [Abstract][Full Text] [Related]
31. T cell prolymphocytic leukemia with new chromosome rearrangements.
Zver S; Kokalj Vokac N; Zagradisnik B; Erjavec A; Zagorac A; Zupan IP; Cernelc P
Acta Haematol; 2004; 111(3):168-70. PubMed ID: 15034240
[TBL] [Abstract][Full Text] [Related]
32. T-cell receptor gammadelta T-cell leukemia with the morphology of T-cell prolymphocytic leukemia and a postthymic immunophenotype.
Sugimoto T; Imoto S; Matsuo Y; Kojima K; Yasukawa M; Murayama T; Kohfuku J; Mizuno I; Yakushijin K; Sada A; Nishimura R; Koizumi T
Ann Hematol; 2001 Dec; 80(12):749-51. PubMed ID: 11797117
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of cytogenetic abnormalities in T-cell prolymphocytic leukemia.
Hu Z; Medeiros LJ; Fang L; Sun Y; Tang Z; Tang G; Sun T; Quesada AE; Hu S; Wang SA; Pei L; Lu X
Am J Hematol; 2017 May; 92(5):441-447. PubMed ID: 28194886
[TBL] [Abstract][Full Text] [Related]
34. Sezary cell leukaemia: a distinct T cell disorder or a variant form of T prolymphocytic leukaemia?
Pawson R; Matutes E; Brito-Babapulle V; Maljaie H; Hedges M; Mercieca J; Dyer M; Catovsky D
Leukemia; 1997 Jul; 11(7):1009-13. PubMed ID: 9204983
[TBL] [Abstract][Full Text] [Related]
35. A case report of T cell prolymphocytic leukemia and Kaposi sarcoma and a review of T cell prolymphocytic leukemia.
Paul RN; Alizadeh L; Ajayi OI; Karpurapu H; Ganesan C; Taddesse-Heath L; Aggarwal A
Acta Haematol; 2012; 127(4):235-43. PubMed ID: 22517037
[TBL] [Abstract][Full Text] [Related]
36. T-cell prolymphocytic leukaemia: does the expression of CD8+ phenotype justify the identification of a new subtype? Description of two cases and review of the literature.
Ascani S; Leoni P; Fraternali Orcioni G; Bearzi I; Piccioli M; Materazzi M; Zinzani PL; Gherlinzoni F; Falini B; Pileri SA
Ann Oncol; 1999 Jun; 10(6):649-53. PubMed ID: 10442186
[TBL] [Abstract][Full Text] [Related]
37. Sezary cell-like leukemia: a distinct type of mature T cell malignancy.
Matutes E; Keeling DM; Newland AC; Scott CS; Mitchell D; Traub N; Wardle DG; Catovsky D
Leukemia; 1990 Apr; 4(4):262-6. PubMed ID: 2366582
[TBL] [Abstract][Full Text] [Related]
38. Recurrent mutation of JAK3 in T-cell prolymphocytic leukemia.
Bergmann AK; Schneppenheim S; Seifert M; Betts MJ; Haake A; Lopez C; Maria Murga Penas E; Vater I; Jayne S; Dyer MJ; Schrappe M; Dührsen U; Ammerpohl O; Russell RB; Küppers R; Dürig J; Siebert R
Genes Chromosomes Cancer; 2014 Apr; 53(4):309-16. PubMed ID: 24446122
[TBL] [Abstract][Full Text] [Related]
39. Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified.
Kawamoto K; Miyoshi H; Yanagida E; Yoshida N; Kiyasu J; Kozai Y; Morikita T; Kato T; Suzushima H; Tamura S; Muta T; Kato K; Eto T; Seki R; Nagafuji K; Sone H; Takizawa J; Seto M; Ohshima K
Eur J Haematol; 2017 May; 98(5):459-466. PubMed ID: 28129454
[TBL] [Abstract][Full Text] [Related]
40. [Cutaneous infiltration by T-cell prolymphocytic leukemia in two adult patients].
Mateos-Mayo A; Sánchez-Herrero A; Nieto-Benito LM; Parra-Blanco V; Suárez-Fernández R; Pulido-Pérez A
Rev Med Inst Mex Seguro Soc; 2020 Sep; 58(5):628-633. PubMed ID: 34520151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
